Kai‐Wen Huang

MTL-CEBPA, a Small Activating RNA Therapeutic Upregulating C/EBP-α, in Patients with Advanced Liver Cancer: A First-in-Human, Multicenter, Open-Label, Phase I Trial

Debashis Sarker, Ruth Plummer, Tim Meyer et al. · Clinical Cancer Research · 2020 · 175 citations · Full text

Medicine, Oncology, Pharmacology +17

Novel RNA oligonucleotide improves liver function and inhibits liver carcinogenesis in vivo

Vikash Reebye, Pål Sætrom, Paul J. Mintz et al. · Hepatology · 2013 · 121 citations · Full text

Medicine, Molecular Biology, Oncology +17

Management consensus guideline for hepatocellular carcinoma: 2020 update on surveillance, diagnosis, and systemic treatment by the Taiwan Liver Cancer Association and the Gastroenterological Society of Taiwan

Yu‐Yun Shao, Shen-Yung Wang, Shi‐Ming Lin et al. · Journal of the Formosan Medical Association · 2020 · 114 citations · Full text

Medicine, Oncology, Radiology +17

Gene activation of CEBPA using saRNA: preclinical studies of the first in human saRNA drug candidate for liver cancer

Vikash Reebye, Kai‐Wen Huang, Vivian Lin et al. · Oncogene · 2018 · 100 citations · Full text

Medicine, Oncology, Pharmacology +11

Irreversible electroporation in locally advanced pancreatic cancer: A call for standardization of energy delivery

Robert C.G. Martin, Alan North Durham, Marc G. Besselink et al. · Journal of Surgical Oncology · 2016 · 93 citations · Full text

Medicine, Oncology, Surgery +16